
Keywords: BAMBI; BMP and activin membrane-bound inhibitor; CCM; conditioned cell medium; CCL4; C-C motif chemokine ligand 4; CCL28; C-C motif chemokine ligand 28; CXCL3; C-X-C motif chemokine ligand 3; DAP; 1,5-diaminopentane; ESCC; esophageal squamous cell carcino